Hema Tallman on Incredible Opportunity to Participate in the PPTA 2025 Meetings
Hema Tallman, SVP- Global Head of BioLife Plasma Services at Takeda, shared on LinkedIn:
”I recently had the incredible opportunity to participate in the Plasma Protein Therapeutics Association (PPTA) meetings, both at the Plasma Protein Forum and the Business Forum.
Engaging with fellow industry members during these discussions was enlightening and enriching.
Speaking on a panel at the Business Forum—a meeting dedicated solely to plasma industry members—was a particular highlight.
We delved into crucial topics like ethical decision-making, the importance of industry collaboration, and the need for a broader industry representation in PPTA, which are crucial for driving progress in our field.
I’m proud to represent Takeda and BioLife Plasma Services and contribute to conversations on how we can collectively shape the future, ensure ethical practices, and meet patient needs.
Advocacy, transparency, and education remain paramount as we work towards improving both understanding and perception of the plasma industry across the globe.
Grateful for the opportunity to engage and learn, I look forward to continuing these important efforts alongside my esteemed colleagues to work collectively and collaboratively to meet patient needs!”
Stay updated with Hemostasis Today.
-
Oct 25, 2025, 10:13Meet the 2025 WSO Award Winners for Their Extensive Contributions to Stroke Science
-
Oct 25, 2025, 09:53Aakanksha A Shares The 1st Post in ASH 12-Part Microlearning Series
-
Oct 25, 2025, 09:22Alessandro Bufi Presented SAIDE Project at World Stroke Congress 2025
-
Oct 25, 2025, 09:06A Short Story About a Platelet Named Pippa from Krista Goerger
-
Oct 25, 2025, 08:31Maxime Dely: What if We Could Leukoreduce Without a Filter?
-
Oct 24, 2025, 12:08Julián Alejandro Rivillas Compares Tenecteplase to Low-dose Alteplase: TRACE-5 Interim Phase II Results
-
Oct 24, 2025, 12:03Melissa Glasner on Integration of Gene Therapy Into Hemophilia Care
-
Oct 24, 2025, 11:41Yaping Zhang on Platelet Adhesion Receptors
-
Oct 24, 2025, 11:37Omid Jafari and Colleagues Present the VTE-BERT Natural Language Processing Model
-
Oct 24, 2025, 11:34Insights on IV Thrombolysis and Mechanical Thrombectomy from Benjamin Maier and Colleagues
-
Oct 23, 2025, 09:57Arun V. J: Artificial Blood Is Closer Than You Think
-
Oct 23, 2025, 07:11Sebastien Lobet Presented the ACTIVLIM-Hemo Scale
-
Oct 23, 2025, 07:05Syed Ehsan Shah on Advantages of Werfen HemoCell Automation
-
Oct 22, 2025, 08:25Johanna Nystedt: Not Every Day We Can Release a New Blood Product to Meet An Unmet Medical Need!
-
Oct 21, 2025, 06:58Arno Nierich: How Caffeine Affects Red Blood Cells and Blood Storage
-
Oct 25, 2025, 09:32Sylaja Pn Wins 2025 WSO Presidential Award
-
Oct 25, 2025, 08:21Courtney Lawrence: Listen. Empower. Deliver. Save Lives!
-
Oct 25, 2025, 08:14Hema Tallman on Incredible Opportunity to Participate in the PPTA 2025 Meetings
-
Oct 24, 2025, 11:28Louise Bannon and Thomas Reiser Thank World Thrombosis Day Supporters Around The World
-
Oct 24, 2025, 10:48Melanie Daniel Congratulates Mickael Rosa and Antoine Rauch on Winning Bernd R. Binder Prize